| Autor: |
Smirnov LD, Inchina VI, Kostin IaV, Kokoreva EV, Bogoliubova ZhV |
| Jazyk: |
ruština |
| Zdroj: |
Biomeditsinskaia khimiia [Biomed Khim] 2004 Sep-Oct; Vol. 50 (5), pp. 502-8. |
| Abstrakt: |
On model of experimental diabetes in rats the possibility of correction of impairments of lipid, carbohydrate and albumin metabolism by SEMOP in a dose of 25 or 5 mg/kg, dimephosphone (100 mg/kg) and alpha-tocopherol (25 mg/kg) has been Advantage of SEMOP consists in its ability to decrease a level of total protein and albumin of blood of animals with experimental diabetes. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
